| Literature DB >> 8605778 |
L L Moore1, R Valuck, C McDougall, W Fink.
Abstract
With the recent introduction and growing popularity of Depo-Provera Contraceptive Injection, concern about the potential for weight gain during treatment has been raised. The purpose of the present study was to determine whether or not Depo-Provera Contraceptive Injection is associated with greater weight gain, and incidence thereof, than Norplant implants or oral contraceptives. A retrospective chart review of patients seen at a state- and federally-funded clinic was conducted. Fifty women in each treatment group who met the study criteria were identified and included in the study evaluation. Mean one-year weight gain for subjects in each group was as follows: -2.0 pounds in the oral contraceptive group, -1.8 pounds in the Norplant implants group, and +0.1 pounds in the Depo-Provera Contraceptive Injection group. While results among treatment groups differed slightly, no significant weight change occurred in any of the treatment groups.Entities:
Keywords: Americas; Arizona; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Implants; Contraceptive Methods; Depo-provera; Developed Countries; Family Planning; Levonorgestrel; Medroxyprogesterone Acetate; North America; Northern America; Oral Contraceptives; Research Methodology; Research Report; Retrospective Studies; Studies; United States
Mesh:
Substances:
Year: 1995 PMID: 8605778 DOI: 10.1016/0010-7824(95)00189-h
Source DB: PubMed Journal: Contraception ISSN: 0010-7824 Impact factor: 3.375